Mylan N.V. (NASDAQ:MYL)‘s stock had its “buy” rating reissued by research analysts at Mizuho in a research note issued to investors on Wednesday. They currently have a $37.00 price target on the stock. Mizuho’s price target would indicate a potential downside of 2.12% from the company’s previous close.

A number of other analysts have also weighed in on the stock. UBS AG restated a “buy” rating and set a $46.00 target price on shares of Mylan N.V. in a research note on Thursday. Instinet restated a “buy” rating and set a $37.00 target price on shares of Mylan N.V. in a research note on Thursday. Cowen and Company restated a “market perform” rating and set a $36.00 target price (up from $30.00) on shares of Mylan N.V. in a research note on Thursday. Wells Fargo & Company restated a “market perform” rating and set a $32.00 target price (up from $30.00) on shares of Mylan N.V. in a research note on Wednesday. Finally, Cantor Fitzgerald restated a “hold” rating and set a $34.00 target price on shares of Mylan N.V. in a research note on Wednesday. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating, twelve have assigned a buy rating and one has given a strong buy rating to the stock. Mylan N.V. currently has a consensus rating of “Buy” and an average target price of $42.04.

Mylan N.V. (MYL) traded up 0.26% during mid-day trading on Wednesday, hitting $37.90. 8,903,641 shares of the stock were exchanged. The firm has a market cap of $20.33 billion, a P/E ratio of 30.64 and a beta of 1.30. The company has a 50 day moving average of $31.65 and a 200 day moving average of $36.47. Mylan N.V. has a 12-month low of $29.39 and a 12-month high of $45.87. Mylan N.V. also was the recipient of unusually large options trading activity on Wednesday. Stock traders acquired 10,562 put options on the company. This represents an increase of 461% compared to the typical daily volume of 1,883 put options.

Mylan N.V. (NASDAQ:MYL) last released its earnings results on Wednesday, August 9th. The company reported $1.10 earnings per share for the quarter, missing the Zacks’ consensus estimate of $1.18 by ($0.08). Mylan N.V. had a return on equity of 22.42% and a net margin of 5.51%. The firm had revenue of $2.96 billion for the quarter, compared to analysts’ expectations of $3 billion. During the same quarter in the previous year, the company posted $1.16 earnings per share. The firm’s quarterly revenue was up 15.7% on a year-over-year basis. On average, equities analysts anticipate that Mylan N.V. will post $4.52 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “Mylan N.V. (MYL) Rating Reiterated by Mizuho” was first published by American Banking News and is the property of of American Banking News. If you are accessing this story on another site, it was copied illegally and republished in violation of US & international trademark & copyright law. The correct version of this story can be read at https://www.americanbankingnews.com/2017/10/05/mylan-n-v-myl-rating-reiterated-by-mizuho.html.

Several hedge funds have recently bought and sold shares of the company. Wellington Management Group LLP lifted its holdings in shares of Mylan N.V. by 2.6% during the first quarter. Wellington Management Group LLP now owns 46,373,108 shares of the company’s stock worth $1,808,088,000 after purchasing an additional 1,165,852 shares during the period. BlackRock Inc. lifted its holdings in shares of Mylan N.V. by 4.5% during the second quarter. BlackRock Inc. now owns 40,574,158 shares of the company’s stock worth $1,575,089,000 after purchasing an additional 1,751,515 shares during the period. Vanguard Group Inc. lifted its holdings in shares of Mylan N.V. by 12.0% during the second quarter. Vanguard Group Inc. now owns 32,880,790 shares of the company’s stock worth $1,276,432,000 after purchasing an additional 3,531,974 shares during the period. State Street Corp lifted its holdings in shares of Mylan N.V. by 1.6% during the second quarter. State Street Corp now owns 20,498,541 shares of the company’s stock worth $795,751,000 after purchasing an additional 321,977 shares during the period. Finally, Pzena Investment Management LLC lifted its holdings in shares of Mylan N.V. by 69.9% during the second quarter. Pzena Investment Management LLC now owns 12,339,687 shares of the company’s stock worth $479,027,000 after purchasing an additional 5,077,371 shares during the period. 71.97% of the stock is owned by institutional investors and hedge funds.

About Mylan N.V.

Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.

Analyst Recommendations for Mylan N.V. (NASDAQ:MYL)

Receive News & Ratings for Mylan N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan N.V. and related companies with MarketBeat.com's FREE daily email newsletter.